Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

227.86
-0.0400-0.02%
Post-market: 226.00-1.8600-0.82%16:32 EDT
Volume:1.54M
Turnover:353.86M
Market Cap:25.15B
PE:25.18
High:233.21
Open:228.00
Low:223.42
Close:227.90
52wk High:237.78
52wk Low:165.78
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.96
T/O Rate:1.40%
Dividend:3.32
Dividend Rate:1.46%
EPS(TTM):9.05
EPS(LYR):8.75
ROE:14.54%
ROA:6.35%
PB:3.41
PE(LYR):26.04

Loading ...

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Roche Holding AG (OtherRHHVF) and Quest Diagnostics (DGX)

TIPRANKS
·
Yesterday

Quest Diagnostics is Maintained at Neutral by Baird

Dow Jones
·
Yesterday

Quest Diagnostics Lifts Outlook After Strong Earnings

TIPRANKS
·
Yesterday

Quest Diagnostics Declares Gross Dividend of R$ 1.48 Per Unit, Payable July 28

Reuters
·
Yesterday

Quest Diagnostics price target raised to $245 from $225 at Jefferies

TIPRANKS
·
Yesterday

Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning

Benzinga
·
Yesterday

Evercore ISI Cuts Quest Diagnostics Price Target to $240 From $225

MT Newswires Live
·
Yesterday

Quest Diagnostics up over 10%, on Pace for Record High Close

Dow Jones
·
Jul 23

Stock Track | Quest Diagnostics Soars 11.54% Intraday After Q2 Earnings Crush Estimates and Full-Year Guidance Lifted

Stock Track
·
Jul 23

Movement Alert|Quest Diagnostics Rises 8.71% in Regular Trading, Q2 Earnings Beat Expectations by 10% with Full-Year Guidance Raised

Market Focus
·
Jul 23

Quest Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 23

Quest Diagnostics Exec Says Fewer Physician Requests are Being Offset by More Tests Per Request in Aca Exchange Business - Conf Call

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Exec Says Health Plan Pricing Remains Flat to Slightly Positive, Hospital Reference Business Pricing Slightly Negative - Conf Call

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Exec Says Expects Nova Expenses in Second Half to Account for About 70% of Full-year Total, vs Prior Expectation of 60% - Conf Call

THOMSON REUTERS
·
Jul 23

Quest Diagnostics Raises Annual Forecast on Testing Demand

Reuters
·
Jul 23

Quest Climbs After Raising Annual Profit Forecast

Reuters
·
Jul 23

Quest Diagnostics Lifts FY View on Higher 2Q Sales, Profit

Dow Jones
·
Jul 23

Movement Alert|Quest Diagnostics Rises 6.28% in Pre-Market Trading, Q2 Earnings Beat Estimates and Full-Year Guidance Raised

Market Focus
·
Jul 23

GUIDANCE: (DGX) Quest Diagnostics Expects Full Year 2026 Revenue Range $11.95B - $12.05B, vs. FactSet Est of $11.85B

MT Newswires Live
·
Jul 23

Quest Diagnostics reports Q2 adjusted EPS $3.12, consensus $2.82

TIPRANKS
·
Jul 23